Best in 7 days 🦷 BPC-157 & TB-500: Experimental peptides showing preclinical promise for faster oral healing, reduced gum inflammation & bone support in animal studies. Not FDA-approved for dentistry — research US$ 21.21 Sold : Login>>
Good looking results for Novo Nordisk's combo of GLP1ra semaglutide (known as #ozempic for #diabetes & #wegovy for obesity) + Cagrilintide (amylin agonist) to achieve #weightloss in obesity and obesity with type US$ 21.54 Min. order: 1 piece ★★★★★ 4.9 (156 reviews) Sold : Login>>
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants - Gabe - 2024 - Diabetes, Obesity and Metabolism US$ 21.97 Min. order: 1 piece ★★★★★ 4.4 (189 reviews) Sold : Login>>
CagriSema: The New GLP 1 and Amylin Combination That May Transform Obesity Treatment US$ 21.06 Min. order: 1 piece ★★★★★ 4.2 (75 reviews) Sold : Login>>
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 US$ 22.39 Min. order: 1 piece ★★★★★ 4.0 (24 reviews) Sold : Login>>
Updates in Medicine | 🔬 REDEFINE 2: CagriSema in T2D + Obesity Original article link in bio 👥 Phase 3a RCT in 1206 adults with T2D (BMI ≥27, HbA1c 7–10%) 💉 US$ 24.45 Min. order: 1 piece ★★★★★ 5.0 (10 reviews) Sold : Login>>
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial US$ 24.31 Min. order: 1 piece ★★★★★ 4.4 (172 reviews) Sold : Login>>